Macrophage activation syndrome associated with tocilizumab treatment in adult-onset Still's disease.

Tsuchida, Yumi; Sumitomo, Shuji; Shoda, Hirofumi; Kubo, Kanae; Fujio, Keishi; Yamamoto, Kazuhiko

Tsuchida, Yumi; Sumitomo, Shuji; Shoda, Hirofumi; Kubo, Kanae; Fujio, Keishi; Yamamoto, Kazuhiko.

Afiliação

Tsuchida Y; a Department of Allergy and Rheumatology, Graduate School of Medicine , The University of Tokyo , Bunkyo-ku , Tokyo , Japan.
Sumitomo S; a Department of Allergy and Rheumatology, Graduate School of Medicine , The University of Tokyo , Bunkyo-ku , Tokyo , Japan.
Shoda H; a Department of Allergy and Rheumatology, Graduate School of Medicine , The University of Tokyo , Bunkyo-ku , Tokyo , Japan.
Kubo K; a Department of Allergy and Rheumatology, Graduate School of Medicine , The University of Tokyo , Bunkyo-ku , Tokyo , Japan.
Fujio K; a Department of Allergy and Rheumatology, Graduate School of Medicine , The University of Tokyo , Bunkyo-ku , Tokyo , Japan.
Yamamoto K; a Department of Allergy and Rheumatology, Graduate School of Medicine , The University of Tokyo , Bunkyo-ku , Tokyo , Japan.

Mod Rheumatol ; 27(3): 556-557, 2017 05.

Article em En | MEDLINE | ID: mdl-27778518

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Mod Rheumatol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google